Stockscreener 앱 받기
5.345
1.93%
-0.105
시간 외 거래:
5.35
0.005
+0.09%
전일 마감가:
$5.45
열려 있는:
$5.44
하루 거래량:
52,682
Relative Volume:
0.01
시가총액:
$3.48M
수익:
-
순이익/손실:
$-8.74M
주가수익비율:
-2.6073
EPS:
-2.05
순현금흐름:
$-8.25M
1주 성능:
-7.53%
1개월 성능:
-15.23%
6개월 성능:
+262.13%
1년 성능:
-83.19%
1일 변동 폭
$5.11
$5.55
1주일 범위
$5.11
$6.14
52주 변동 폭
$0.0927
$62.60
Glucotrack Inc Stock (GCTK) Company Profile
명칭
Glucotrack Inc
전화
972 (8) 675-7878
주소
301 RT 17 NORTH, RUTHERFORD
GCTK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
5.345 | 3.48M | 0 | -8.74M | -8.25M | -2.05 |
|
ISRG
Intuitive Surgical Inc
|
512.64 | 188.99B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.27 | 50.05B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.92 | 43.06B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
254.25 | 37.62B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
224.38 | 15.84B | 2.90B | 467.20M | 306.90M | 6.37 |
Glucotrack Inc 주식(GCTK)의 최신 뉴스
Why GlucoTrack Inc. stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
How GlucoTrack Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.2% – Here’s What Happened - Defense World
What makes GlucoTrack Inc. stock price move sharplyFree Access to Investment Community - Newser
Implantable glucose monitor competitor emerges with early data - MedTech Dive
GlucoTrack Completes Major Warrant Repurchase - TipRanks
Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy - Nasdaq
Glucotrack Announces Repurchase of Series A Warrants - TradingView
U.S. Stock Movers Today: ULY, NNNN, QS, GCTK, RITR - Markets.com
GlucoTrack Innovation’s Surprise Move: What’s Next? - timothysykes.com
GlucoTrack Inc (NASDAQ: GCTK) – An Analysis Is What You Need - Stocksregister
GlucoTrack (NASDAQ:GCTK) Shares Up 2.6% – What’s Next? - Defense World
Why Did GlucoTrack Plunge 10.71% After Reverse Stock Split? - AInvest
Glucotrack announces 1:60 reverse stock split - Investing.com
GlucoTrack Implements Reverse Stock Split - TipRanks
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - mx.advfn.com
Glucotrack announces 1-for-60 reverse stock split effective June 16 By Investing.com - Investing.com South Africa
Glucotrack announces 1-for-60 reverse stock split effective June 16 - Investing.com Nigeria
GlucoTrack Announces 1-for-60 Reverse Stock Split - TipRanks
Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan
Glucotrack’s Innovative Approach to Diabetes Management Sets New Standards - citybuzz -
Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management - Nasdaq
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com
GlucoTrack to Present at ADA Scientific Sessions - TipRanks
Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions - The Manila Times
GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low, hits $0.13 - Investing.com India
Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail
Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa
Glucotrack appoints new board member with diabetes tech expertise - Investing.com
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times
GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World
GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks
GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia
GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria
GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times
Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq
Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan
Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -
Glucotrack Inc (GCTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.95%
자본화:
|
볼륨(24시간):